Back
For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".
To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".
During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center.
Preparing your E-Poster
Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.
E-Poster Submission Deadline
Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.
Please follow the instructions below to input your abstract title.
Abstract titles should be brief and reflect the content of the abstract.
Snakebite envenoming is a global public health issue, reclassified by WHO as a neglected tropical disease. In Brazil, Bothrops species cause 80–90% of cases, with high morbidity and mortality). Fatalities are often associated with systemic bleeding, shock, respiratory failure, and acute kidney injury (AKI), the main cause of death in snakebite victims.
Case report: A 65-year-old rural worker was bitten on the fifth right toe, presenting pain, edema, paresthesia, and clotting time >30 min. Admission laboratory values are summarized in Table 1. Initially classified as mild, he received three vials of antibothropic serum. Four hours later, he developed hypotension, blurred vision, abdominal pain, anemia, and thrombocytopenia (Table 1[GB1] ). Reclassified as severe, he received nine more vials, but died ten hours post-bite. Necropsy revealed edema and punctiform lesions on the right foot, moderate hemothorax, intense pulmonary congestion, softened liver, and cerebral edema with intraparenchymal hemorrhages. Although no macroscopic renal alterations were noted, the clinical course suggested high risk of AKI due to shock, coagulopathy, and hemolysis, mechanisms well established in Bothrops accidents.
Parameters
8h
(admission)
12h
Reference values
Hemoglobin (g/dL)
13.9
7.4g
12-17
Hematocrit (%)
43.8
23.3
36-50
Platelets (/dL)
187.000
133.000
150-400 x 10³
Leukocytes (/dL)
10.500
13.000
5-11 x 10³
Segmented (%)
71
73
45-70
Band cells (%)
2
0
Clotting time (min)
>30
*
5-10
Creatinine (mg/dL)
1
<1.5
Urea (mg/dL)
42
10-50
Table 1
Bothropic venom exerts proteolytic, coagulant, and hemolytic effects, leading to edema, coagulopathy, and systemic bleeding. Complications such as hemorrhage, shock, sepsis, respiratory failure, and especially AKI are strongly associated with mortality. Older victims usually show worse prognosis due to reduced renal reserve and comorbidities. In this case, deterioration occurred despite reclassification and serum therapy in accordance with guidelines. Necroscopic findings aligned with previously described Viperidae cases.
Fatal Bothrops cases often involve systemic bleeding, shock, and AKI. This case emphasizes the need for vigilant monitoring, early reclassification, and recognition of renal risk even before laboratory evidence of AKI. Necroscopic findings reinforce the systemic effects of the venom and support improvements in snakebite care and prevention strategies
